July 21, 2021
Conducting a transparent, targeted and robust benefit-risk assessment of a new drug or product is one of the most..
Read article
March 2, 2021
Most people know that clinical drug discovery is usually conducted using either Frequentist or Bayesian methods. These..
Read article
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..
Read article
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..
Read article
May 30, 2017
A recent paper The case for Bayesian methods in benefit-risk assessment: Overview and future directions..
Read article
